HLA Alleles are Genetic Markers for Susceptibility and Resistance towards Leprosy in a Mexican Mestizo Population

Despite the use of multidrug therapy, leprosy remains endemic in some countries. The association of several human leucocyte antigen (HLA) alleles and gene polymorphisms with leprosy has been demonstrated in many populations, but the major immune contributors associated to the spectrum of leprosy have not been defined yet. In this study, genotyping of HLA‐A, ‐B, ‐DR, and ‐DQ alleles was performed in leprosy patients (n = 113) and control subjects (n = 117) from the region with the highest incidence for the disease in México. The odds of developing leprosy and lepromatous subtype were 2.12‐ and 2.74‐fold higher in carriers of HLA‐A*28, and 2.48‐ and 4.14‐fold higher for leprosy and dimorphic subtype in carriers of DQB1*06. Interestingly, DQB1*07 was overrepresented in healthy individuals, compared to patients with leprosy (OR = 0.08) and the lepromatous subtype (OR = 0.06). These results suggest that HLA‐A*28 is a marker for predisposition to leprosy and the lepromatous subtype and DQB1*06 to leprosy and the dimorphic subtype, while DQB1*07 might be a resistance marker in this Mestizo population.

[1]  Yong-Gang Yao,et al.  Fine mapping of the GWAS loci identifies SLC35D1 and IL23R as potential risk genes for leprosy. , 2016, Journal of dermatological science.

[2]  F. C. de Souza-Santana,et al.  Human leukocyte antigen class I and class II alleles are associated with susceptibility and resistance in borderline leprosy patients from Southeast Brazil , 2015, BMC Infectious Diseases.

[3]  Christopher R. Gignoux,et al.  The genetics of Mexico recapitulates Native American substructure and affects biomedical traits , 2014, Science.

[4]  J. Granados,et al.  Association of genetic polymorphism of HLA-DRB1 antigens with the susceptibility to lepromatous leprosy. , 2013, Biomedical reports.

[5]  P. Fine,et al.  Patterns and trends of leprosy in Mexico: 1989-2009. , 2012, Leprosy review.

[6]  Liangdan Sun,et al.  Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy , 2011, Nature Genetics.

[7]  L. Abel,et al.  Leprosy as a genetic disease , 2011, Mammalian Genome.

[8]  T. Hawn,et al.  Leprosy and the Human Genome , 2010, Microbiology and Molecular Biology Reviews.

[9]  D. Malhotra,et al.  Leprosy and the Adaptation of Human Toll-Like Receptor 1 , 2010, PLoS pathogens.

[10]  Ying Wang,et al.  Genomewide association study of leprosy. , 2009, The New England journal of medicine.

[11]  D. Scollard.  The biology of nerve injury in leprosy. , 2008, Leprosy review.

[12]  Karina Marinic,et al.  Papel de las moléculas HLA-DR y HLA-DQ en la lepra multibacilar y paucibacilar en la provincia del Chaco; Argentina , 2007 .

[13]  Meenakshi Singh,et al.  Stepwise replication identifies a low-producing lymphotoxin-α allele as a major risk factor for early-onset leprosy , 2007, Nature Genetics.

[14]  L. Abel,et al.  Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. , 2006, Seminars in immunology.

[15]  T. Ottenhoff,et al.  HLA and leprosy in the pre and postgenomic eras. , 2006, Human immunology.

[16]  Diana J L Williams,et al.  The Continuing Challenges of Leprosy , 2006, Clinical Microbiology Reviews.

[17]  M. Mira.  Genetic host resistance and susceptibility to leprosy. , 2006, Microbes and infection.

[18]  J. Casanova,et al.  Genetic dissection of immunity in leprosy. , 2005, Current opinion in immunology.

[19]  F. Vargas‐Ocampo,et al.  Analysis of 6000 skin biopsies of the national leprosy control program in Mexico. , 2004, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[20]  U. Shankarkumar.  HLA associations in leprosy patients from Mumbai, India. , 2004, Leprosy review.

[21]  T. Hudson,et al.  Susceptibility to leprosy is associated with PARK2 and PACRG , 2004, Nature.

[22]  D. Mohanty,et al.  Novel HLA Class I Alleles Associated with Indian Leprosy Patients , 2003, Journal of biomedicine & biotechnology.

[23]  T. Hudson,et al.  Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population , 2003, Nature Genetics.

[24]  R. Pitchappan,et al.  A major susceptibility locus for leprosy in India maps to chromosome 10p13 , 2001, Nature Genetics.

[25]  T. Ottenhoff,et al.  Definition of a human suppressor T-cell epitope. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Piero Carninci,et al.  A fast method for high-quality genomic DNA extraction from whole human blood. , 1991, BioTechniques.

[27]  T. Ottenhoff,et al.  HLA‐DQ molecules and the control of Mycobacterium leprae‐specific T cell nonresponsiveness in lepromatous leprosy patients , 1990, European journal of immunology.

[28]  C. Gorodezky,et al.  Tuberculoid leprosy in Mexicans is associated with HLA-DR3. , 1987, Leprosy review.

[29]  T. Ottenhoff,et al.  HLA class II immune response and suppression genes in leprosy. , 1987, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[30]  P. Terasaki,et al.  Histocompatibility antigens in patients with leprosy. , 1976, The Journal of infectious diseases.

[31]  D P Byar,et al.  How many controls? , 1976, Journal of chronic diseases.

[32]  C. Gorodezky,et al.  Distribution of Some of the HL‐A System Lymphocyte Antigens in Mexicans , 1972, Vox sanguinis.

[33]  B. Woolf.  ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.

[34]  M. Mira,et al.  Genetics of leprosy: Expected-and unexpected-developments and perspectives. , 2016, Clinics in dermatology.

[35]  M. Mira,et al.  Genetics of leprosy: expected and unexpected developments and perspectives. , 2015, Clinics in dermatology.

[36]  M. L. Molinari,et al.  [Role of HLA-DR and HLA-DQ alleles in multibacillary leprosy and paucibacillary leprosy in the province of Chaco (Argentina)]. , 2007, Enfermedades infecciosas y microbiologia clinica.

[37]  C. Gorodezky,et al.  Molecular mechanisms of MHC linked susceptibility in leprosy: towards the development of synthetic vaccines. , 2004, Tuberculosis.

[38]  J. Casanova,et al.  The human model: a genetic dissection of immunity to infection in natural conditions , 2004, Nature Reviews Immunology.

[39]  A. Hill,et al.  The immunogenetics of human infectious diseases. , 1998, Annual review of immunology.

[40]  H GRUNEBERG,et al.  Human genetics. , 1947, The Eugenics review.